Health & Environmental Research Online (HERO)


Print Feedback Export to File
781988 
Journal Article 
Pulmonary inflammatory and fibrotic responses in Fischer 344 rats after intratracheal instillation exposure to Libby amphibole 
Padilla-Carlin, DJ; Schladweiler, MCJ; Shannahan, JH; Kodavanti, UP; Nyska, A; Burgoon, LD; Gavett, SH 
2011 
Journal of Toxicology and Environmental Health, Part A: Current Issues
ISSN: 1528-7394
EISSN: 1087-2620 
74 
17 
1111-1132 
English 
Increased incidences of asbestosis have been reported in workers from Libby, MT, associated with exposures to amphibole-contaminated vermiculite. In this study pulmonary and histopathological changes were investigated following Libby amphibole (LA) exposure in a rat model. Rat respirable fractions of LA and amosite (aerodynamic diameter <2.5 μm) were prepared by water elutriation. Male F344 rats were exposed to single doses of either saline (SAL), amosite (0.65 mg/rat), or LA (0.65 or 6.5 mg/rat) by intratracheal instillation. At times from 1 d to 3 mo after exposure, bronchoalveolar lavage (BAL) was performed and right and left lungs were removed for reverse-transcription polymerase chain reaction (RT-PCR) and histopathological analysis, respectively. Data indicated that 0.65 mg amosite resulted in a higher degree of pulmonary injury, inflammation, and fibrotic events than LA at the same mass dose. Exposure to either amosite or high dose LA resulted in higher levels of cellular permeability and injury, inflammatory enzymes, and iron binding proteins in both BAL fluid and lung tissue at most time points when compared to SAL controls. However, mRNA expression for some growth factors (e.g., platelet-derived growth factor [PDGF]-A and transforming growth factor [TGF]-1β), which contribute to fibrosis, were downregulated at several time points. Furthermore, histopathological examination showed notable thickening of interstitial areas surrounding the alveolar ducts and terminal bronchioles. On a mass dose basis, amosite produced a greater acute and persistent lung injury for at least 3 mo after exposure. However, further testing and analysis of LA are needed with regard to the dose metric to fully evaluate its potential fibrogenicity and carcinogenicity. 
Pharmacy And Pharmacology; Pathology; Histology; Rodents; Toxicology 
IRIS
• Asbestos
• Libby Amphibole Asbestos (Draft, 2011)
OPPT REs
• OPPT_Asbestos, Part I: Chrysotile_C. Engineering
     Total – title/abstract screening
          Off topic
• OPPT_Asbestos, Part I: Chrysotile_D. Exposure
     Total – title/abstract screening
          Off topic
• OPPT_Asbestos, Part I: Chrysotile_E. Fate
     Total – title/abstract screening
          Off topic
• OPPT_Asbestos, Part I: Chrysotile_F. Human Health
     Total – title/abstract screening
          On topic
               Peer review
                    Primary source
     Other forms of asbestos
• OPPT_Asbestos, Part I: Chrysotile_Supplemental Search
     LitSearch: Sept 2020 (Undated)
          ProQuest
          PubMed
          Toxline
          WoS
     Vermiculite
     Legacy Uses
          Health Outcomes
               Additional Legacy Terms
          Exposure
               Additional Legacy Terms
          Suggested Legacy References